Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ESCAPE-IT
NCT02687178Phase 4Completed
- Sponsor
- University of Pavia
- Start
- Oct 2010
- Primary completion
- Oct 2015
- Modality
- Nucleic Acid-Directed Small Molecules, Orthosteric Ligands
01
Overview
A Phase 4 trial of canrenone in essential hypertension, sponsored by University of Pavia. Started Oct 2010; status: completed.
02
Drugs
canrenone
03
Conditions
essential hypertension
Beyond the preview
Go deeper on NCT02687178.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02687178.